Ambu A/S banner

EV/EBIT

22.4
Current
59%
Cheaper
vs 3-y average of 55.1

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
22.4
=
Enterprise Value
$18B
/
EBIT
kr705m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
22.4
=
Enterprise Value
$18B
/
EBIT
kr705m

Valuation Scenarios

Ambu A/S is trading below its 3-year average

If EV/EBIT returns to its 3-Year Average (55.1), the stock would be worth $33.54 (146% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-39%
Maximum Upside
+411%
Average Upside
122%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 22.4 $13.65
0%
3-Year Average 55.1 $33.54
+146%
5-Year Average 114.6 $69.79
+411%
Industry Average 15.5 $9.42
-31%
Country Average 13.6 $8.28
-39%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
$18B
/
Jan 2026
kr705m
=
22.4
Current
$18B
/
Sep 2026
kr847m
=
21.3
Forward
$18B
/
Sep 2027
kr1.1B
=
15.8
Forward
$18B
/
Sep 2028
kr1.5B
=
12.2
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
Market Cap EV/EBIT P/E
DK
Ambu A/S
OTC:AMBFF
16.3B USD 22.4 29.8
US
Abbott Laboratories
NYSE:ABT
161B USD 19.1 25.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
160.3B USD 56.5 60.6
US
Stryker Corp
NYSE:SYK
125.2B USD 24.2 39.2
IE
Medtronic PLC
NYSE:MDT
105.2B USD 18.8 23.2
US
Boston Scientific Corp
NYSE:BSX
88.3B USD 26.4 33.2
DE
Siemens Healthineers AG
XETRA:SHL
42.9B EUR 15.6 19.7
US
Edwards Lifesciences Corp
NYSE:EW
46.3B USD 26.1 43.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.4B USD 34.1 43.6
US
Becton Dickinson and Co
NYSE:BDX
44.6B USD 16.9 25.2
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
32.9B USD 13.6 15.6

Market Distribution

Lower than 75% of companies in Denmark
Percentile
25th
Based on 367 companies
25th percentile
5.1
Low
0.8 — 6.6
Typical Range
6.6 — 19.5
High
19.5 —
Distribution Statistics
Denmark
Min 0.8
30th Percentile 6.6
Median 13.6
70th Percentile 19.5
Max 473.6

Ambu A/S
Glance View

Market Cap
3.6B USD
Industry
Health Care

Ambu A/S, a Danish company rooted in innovation, has carved a niche in the global healthcare sector through its specialized medical devices. Founded in 1937, Ambu started with a simple mission of improving patient care and has stayed true to that vision by continuously advancing their portfolio. The company's journey began with the invention of the resuscitator bag, a revolutionary product that remains a staple in emergency and hospital settings today. Over the years, Ambu has focused strategically on three main segments: Anesthesia, Patient Monitoring & Diagnostics, and Visualisation, each playing a crucial role in the broader healthcare ecosystem. These segments allow Ambu to develop devices that enhance diagnostic procedures, improve safety, and increase efficiency in medical settings, ultimately saving lives and optimizing healthcare delivery. Ambu’s business model capitalizes primarily on innovation-driven sales, with a strong emphasis on disposable medical devices which are gaining popularity due to hygiene concerns and regulatory trends favoring single-use technologies. These products include their flagship single-use endoscopes, marketed under the brand name "Ambu aScope," which significantly reduce the risk of cross-contamination while providing high-quality diagnostic images. The company's revenue model is built on a B2B approach, dealing directly with hospitals, clinics, and other healthcare providers, ensuring a steady flow of sales through long-term contracts and partnerships. Through constant reinvestment into R&D and strategic acquisitions, Ambu sustains its market leadership, driving growth by addressing the evolving needs of the healthcare industry and setting standards in patient care solutions globally.

AMBFF Intrinsic Value
17.89 USD
Undervaluation 24%
Intrinsic Value
Price $13.65
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett